If you invest in the stock market, you must know the Glenmark Pharmaceuticals share price target for 2025, 2026, 2027, 2028, 2029, and 2030. Here, you will get detailed information regarding all your queries, such as its financial performance, future predictions, and more.
Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Limited is a well-known medicine company from India. It was founded in 1977, and its headquarters is in Mumbai, Maharashtra.
Glenmark makes medicines and treatments for problems like asthma, skin diseases, and cancer. Glenmark also works on making new and better medicines through research and science.
Many doctors and hospitals use Glenmark’s products because they are safe and trusted. The company’s goal is to help people live healthier lives by giving them the right medical care.
Glenmark Pharmaceuticals Share Price Target Tomorrow
Also Read: Smartworks Coworking Share Price Target 2025 to 2030
Glenmark Pharmaceuticals Share Price Target 2025
- Starting Price: ₹1400
- Mid-Year Price: ₹2100
- Ending Price: ₹2500
Glenmark Pharmaceuticals Share Price Target 2026
- Starting Price: ₹2600
- Mid-Year Price: ₹3100
- Ending Price: ₹3600
Glenmark Pharmaceuticals Share Price Target 2027
- Starting Price: ₹3800
- Mid-Year Price: ₹4300
- Ending Price: ₹4800
Glenmark Pharmaceuticals Share Price Target 2028
- Starting Price: ₹5000
- Mid-Year Price: ₹5500
- Ending Price: ₹6000
Glenmark Pharmaceuticals Share Price Target 2029
- Starting Price: ₹6100
- Mid-Year Price: ₹6600
- Ending Price: ₹7100
Glenmark Pharmaceuticals Share Price Target 2030
- Starting Price: ₹7000
- Mid-Year Price: ₹7600
- Ending Price: ₹8200
Also Read: TCS Share Price Target 2025, 2026, 2027, 2028, 2029, 2030
FAQs
Question No. 1: What is the price target for Glenmark Pharmaceuticals in 2025?
Answer No. 1✅: The price target for Glenmark Pharmaceuticals in 2025 is projected to range from ₹1400 to ₹2500.
Question No. 2: What is the price target for Glenmark Pharmaceuticals in 2030?
Answer No. 2✅: The price target for Glenmark Pharmaceuticals in 2030 is projected to range from ₹7000 to ₹8200.
Question No. 3: Is Glenmark Pharmaceuticals Ltd a debt-free company?
Answer No. 3✅: No, Glenmark Pharmaceuticals Ltd is not a debt-free company.
Question No. 4: Who is the chairman of Glenmark Pharmaceuticals Ltd?
Answer No. 4✅: The chairman of Glenmark Pharmaceuticals Ltd is Glenn Saldanha.
We have more than 5 years of experience in stock market and analysis, and we are dedicated to delivering accurate, real-time market updates and insightful analysis. With a sharp eye on the Indian and global stock markets, we simplify complex financial data and trends to help investors make informed decisions.
Disclaimer: The stock market updates shared by DateUpdateGo are solely for general information and learning purpose only. They are not meant to serve as an investment advice. Individuals should always seek guidance from a certified financial advisor before making any investment-related choices.